PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$30.77

Market cap

$174.36B

P/E Ratio

N/A

Dividend/share

$1.66

EPS

-$0.05

Enterprise value

$243.18B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
PFE's debt has soared by 94% YoY but it is down by 3.3% from the previous quarter
The quick ratio has contracted by 35% YoY but it has grown by 12% from the previous quarter
Pfizer's net income has shrunk by 115% QoQ and by 101% YoY
Pfizer's EPS has plunged by 113% from the previous quarter and by 101% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.pfizer.com/
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.67B
Market cap
$174.36B
Enterprise value
$243.18B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
3.16
EV/EBIT
N/A
EV/EBITDA
51.82
EV/Sales
4.41
Earnings
Revenue
$55.09B
EBIT
-$1.85B
EBITDA
$4.69B
Free cash flow
$5.11B
Per share
EPS
-$0.05
Free cash flow per share
$0.9
Book value per share
$16.34
Revenue per share
$9.74
TBVPS
$15.73
Balance sheet
Total assets
$221.1B
Total liabilities
$128.54B
Debt
$69.54B
Equity
$92.28B
Working capital
$1.92B
Liquidity
Debt to equity
0.75
Current ratio
1.05
Quick ratio
0.57
Net debt/EBITDA
14.66
Margins
EBITDA margin
8.5%
Gross margin
57.4%
Net margin
-0.6%
Operating margin
-3.3%
Efficiency
Return on assets
-0.1%
Return on equity
-0.3%
Return on invested capital
-1.4%
Return on capital employed
-1%
Return on sales
-3.4%
Dividend
Dividend yield
5.39%
DPS
$1.66
Payout ratio
N/A

PFE stock price

How has the Pfizer stock price performed over time
Intraday
1.95%
1 week
2.67%
1 month
12.22%
1 year
-17.31%
YTD
6.88%
QTD
9.97%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$55.09B
Gross profit
$31.65B
Operating income
-$1.79B
Net income
-$309M
Gross margin
57.4%
Net margin
-0.6%
PFE's net margin has plunged by 117% from the previous quarter and by 102% YoY
Pfizer's net income has shrunk by 115% QoQ and by 101% YoY
The company's operating margin has shrunk by 110% YoY
The operating income has plunged by 106% YoY

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
N/A
P/B
1.88
P/S
3.16
EV/EBIT
N/A
EV/EBITDA
51.82
EV/Sales
4.41
Pfizer's EPS has plunged by 113% from the previous quarter and by 101% YoY
PFE's P/B is 36% below its 5-year quarterly average of 2.9 and 2.6% below its last 4 quarters average of 1.9
Pfizer's equity has decreased by 9% YoY but it has increased by 3.7% QoQ
Pfizer's revenue has decreased by 41% YoY and by 6% QoQ
PFE's P/S is 18% below its 5-year quarterly average of 3.8 but 11% above its last 4 quarters average of 2.8

Efficiency

How efficient is Pfizer business performance
The ROE has shrunk by 114% QoQ and by 101% YoY
Pfizer's ROS has plunged by 110% YoY
Pfizer's ROA has plunged by 110% from the previous quarter and by 101% YoY
The company's return on invested capital has shrunk by 105% YoY

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.66
Dividend yield
5.39%
Payout ratio
N/A
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 72% greater than its total liabilities
The company's total liabilities rose by 36% YoY but it fell by 6% QoQ
The quick ratio has contracted by 35% YoY but it has grown by 12% from the previous quarter
PFE's debt is 25% less than its equity
The debt to equity has soared by 108% YoY but it has contracted by 7% from the previous quarter
PFE's debt has soared by 94% YoY but it is down by 3.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.